“…Examples of such rare populations in blood are EVs originating from cancer cells (Nanou et al., 2023 ; Yang et al., 2018 ), cardiomyocytes (Hegyesi et al., 2022 ) or bacteria (Tulkens et al., 2020 ). Recently, the cellular origin of plasma EVs has also been deduced by measuring the presence of tissue‐specific long RNA sequencing profiles (Li et al., 2020 ) or tissue‐specific protein signatures (Abdelmohsen et al., 2023 ) in plasma or serum. Since EVs are only a small fraction of all particles present in blood, plasma and serum (Johnsen et al., 2019 ; Simonsen, 2017 ), detection of rare EV types is even more challenging.…”